ELISA for the detection of serum. And saliva IgA against the BMRFI gene product of Epstein-Barr virus

Journal of Medical Virology

Volumn 50, Issue 1, 1996, Pages 93-96

  Nadala, E C B ^a   Tan, T M C ^a   Wong, H M ^b   Ting, R C Y ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cancer; Diagnosis; Herpesvirus; Immunoassay

Indexed keywords

IMMUNOGLOBULIN A;

ANTIBODY DETECTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; HUMAN; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; SALIVA; SERUM;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN A; NASOPHARYNGEAL NEOPLASMS; SALIVA; TUMOR VIRUS INFECTIONS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 0029958667     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199609)50:1<93::AID-JMV15>3.0.CO;2-Z     Document Type: Article

References (13)

1. Andersson-Anvret M, Forsby N, Klein G, Henle W (1977): Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: Correlated nucleic acid hybridization and histopathological examination. International Journal of Cancer 20:486-494.
2. Foong YT, Cheng HM, Sam CK, Dillner J, Hinderer W, Prasad U (1990): Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma. International Journal of Cancer 45: 1061-1064.
3. Henle G, Henle W (1976): Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. International Journal of Cancer 17:1-7.
4. Henle W, Henle G, Ho HC, Burtin P, Cachin Y, Clifford P, de Schryver A, de-Thé G, Diehl V, Klein, G (1970): Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms and other control groups. Journal of the National Cancer Institute 44:225-231.
5. Joab I, Nicolas JC, Schwaab G, de-Thé G, Clausse B, Perricaudet M, Zeng Y (1991): Detection of anti-Epstein-Barr virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. International Journal of Cancer 48:647-649.
6. Klein G, Giovanella BC, Lindahl T, Fialkow PJ, Singh S, Stehlin JS (1974): Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proceedings of the National Academy of Science, USA 71:4737-4741.
7. Li JS, Zhou BS, Dutschman GE, Grill SP, Tan RS, Cheng YC (1987): Association of Epstein-Barr virus early antigen diffuse component and virus-specific DNA polymerase activity. Journal of Virology 61:2947-2949.
8. Li W, Jian S, Wang H, Lian Y (1991): IgM antibody to Epstein-Barr virus and nasopharyngeal carcinoma. International Journal of Cancer (China) 10:312-315.
9. Mathew A, Cheng HM, Sam CK, Joab I, Prasad U, Cochet C (1994): A high incidence of serum IgG antibodies to the Epstein-Barr virus replication activator protein in nasopharyngeal carcinoma. Cancer Immunology and Immunotherapy 38:68-70.
10. Pothen S, Cao T, Smith R, Levine PH, Pearson GR (1993): Identification of T- and B-cell epitopes associated with a restricted component of the Epstein-Barr virus-induced early antigen complex. International Journal of Cancer 53:1-6.
11. Raab-Traub N, Flynn K (1986): The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47:883-889.
12. Tsurumi T (1993): Purification and characterization of the DNA-binding activity of Epstein-Barr virus DNA polymerase accessory protein BMRF1 gene products, as expressed in insect cells by using the baculovirus system. Journal of Virology 67:1681-1687.
13. Wara WM, Wara DM, Philips TL, Ammann AJ (1975): Elevated IgA in carcinoma of the nasopharynx. International Journal of Cancer 35:1313-1315.